Please assess the completion status of the following clinical trial:

Trial Title: Use of N-Acetylcysteine During Liver Procurement

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* all consecutive subjects with chronic liver disease undergoing first Liver Transplantation receiving deceased donor livers~Exclusion Criteria:~* recipients with acute liver disease;~* paediatric patients or adult patients receiving a liver from a paediatric donor;~* patients undergoing multiple-organ transplantation;~* patients undergoing re-transplantation of the Liver;~* patients undergoing living donor Liver Transplantation

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- NAC procurement protocol (Type: EXPERIMENTAL): The allocated organ, in addition to the standard procedure, was treated with a systemic NAC infusion before initiating the liver harvesting procedure, and a loco-regional infusion into the portal vein before cross-clamping.
- Standard procurement procedure (Type: NO_INTERVENTION): Allocated organ was treated according to the centre's standard procurement procedure: a modified double perfusion technique, where donor livers are gravity-perfused in situ via the aorta and portal vein with Celsior solution at 4 °C. After hepatectomy, donor livers were further perfused at the back-table with Celsior solution and then stored in conventional bags containing the same solution at 4 °C until transplantation.

Based on this trial design, predict the completion outcome and termination type (if applicable).